There were also some improvements in surrogate markers of fibrosis measured by MRE (36% and 33% of patients in the 10 mg daily and 20 mg weekly arms, respectively, had 15% reduction in liver stiffness compared to 7% in the control arm) and pro-C3, as measured by adjusted percent improvement from baseline (30%, 21% and 1.9% in the 10 mg daily, 20 mg weekly, and placebo arm, respectively)
Order Processing & Shipping: Orders processed within 48 hours
PlexusDx supports both pathways through licensed 503A compounding pharmacies, giving your healthcare provider flexibility to start with one medication and transition if needed
If the mechanism is fairly focused but the dosing schedule is poorly chosen, the observed effects may reflect protocol strain, cumulative exposure patterns, or handling inconsistencies rather than the peptides intended pharmacology